Updated:
30Ventures
30Ventures is a Madison-based early-stage venture firm targeting seed and startup investments with no publicly disclosed principals or portfolio companies.
30Ventures
30Ventures is a venture capital firm investing in early-stage healthcare and biotechnology companies. It focuses on series A and B financing for capital-efficient startups. The firm has made 5 investments, including a Series B-II investment in BlueWillow Biologics on April 08, 2020.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Madison
Corporate office
Madison, WI, United States
Frequently asked questions
Who runs investment decisions at 30Ventures?
No principals are publicly named by 30Ventures. The firm's website and public filings do not identify a managing partner, investment committee, or any individual responsible for capital allocation.
What investment stages does 30Ventures typically target?
The firm's stated strategy covers early-stage, seed, and startup investments. Specific check sizes, ownership targets, or follow-on policies have not been disclosed in any public forum.
Has 30Ventures publicly announced any portfolio companies?
No. There are no press releases, portfolio pages, or third-party reports that connect 30Ventures to any named company or investment.
Is 30Ventures structured as a traditional venture fund or an angel syndicate?
The firm labels itself a private equity firm, but its lack of regulatory filings, team disclosures, and portfolio visibility is more consistent with an informal investment vehicle or angel network than a traditional closed-end venture fund.
How does 30Ventures' profile compare to other venture firms in Madison, Wisconsin?
Madison hosts several identifiable venture firms such as HealthX Ventures and the accelerator gener8tor, both of which publicly report fund sizes, team members, and portfolio companies. 30Ventures' complete opacity makes it an outlier in the region's otherwise transparent early-stage investment community.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: